|Phone||+49 6172 - 13 97 20|
|Description||25 years of successful venture capital|
|Fund III, 9/2011||€80M|
|Fund II, 1/2007||€60M|
|Fund I, 1/2003||€20M|
As a leading European Venture Capital firm, Creathor Venture invests in technology-oriented companies and entrepreneurs. The focus is particulary on mobile, e-, m-, s-commerce, media, cloud, life science, mobile health and diagnostics. Regional focus is on Germany, Switzerland, France, Austria and Scandinavia.
The current portfolio of more than 30 companies is actively supported in development, growth and internationalization by our team of 15 staff. The management team of Creathor Venture consists of the founder of the former Technologieholding VC GmbH, Dr Gert Koehler as well as Karlheinz Schmelig and Cedric Koehler. The team has built more than 200 technology companies successfully, conducted more than 20 international IPOs and has achieved exceptional returns for fund investors and the financed entrepreneurs in the past.
Creathor Venture manages funds of more than EUR 180 million (USD 240m) and currently has four offices (near Frankfurt & Munich, Zurich & Stockholm).
The investors of the current fund (CVIII) include the European Union, through which the fund receives funding from the “Competitiveness and Innovation Framework Programme” (CIP), and the “ERP EIF fund of funds” and the LfA – Gesellschaft für Vermögensverwaltung mbH, both facilities of the European Investment Fund (“EIF”), fund of funds, family offices and entrepreneurs. As the largest investor in Creathor the management underlines its entrepreneurial orientation.
Creathor Ventures was acquired by Shopgate.
|Mobiles Republic||10/2013||Series B||$6M||3|
|SIRION BIOTECH||2013||Venture Round||5|
|Cube Biotech||12/2012||Series A||2|
|Mobiles Republic||3/2012||Series A||$3M||2|
|Sividon Diagnostics||9/2011||Venture Round||3|
|CEVEC Pharmaceuticals||7/2011||Venture Round||€6M||2|
|SIRION BIOTECH||6/2011||Venture Round||4|
|Phenex Pharmaceuticals||9/2010||Series C||€6M||5|
|Caprotec Bioanalytics||5/2010||Series B||$5.1M||4|
|CEVEC Pharmaceuticals||2/2010||Series B||$5.4M||3|
|aka-aki networks||10/2009||Venture Round||2|
|Mobiles Republic||2/2009||Venture Round||1|
|Caprotec Bioanalytics||1/2008||Venture Round||$8.8M||3|